Already a member? Login to access this report free.
Report Highlights
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Report Includes
- 220 data tables and 59 additional tables
- An analysis of the global markets for single-use technologies for biopharmaceutical manufacturing
- Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the size and revenue prospects of the global market, along with a market share analysis by technology, single-use component, application, end user, and region/country
- A look at recent technical advances in different sole-use technologies and bioreactors and the extent of adoption by commercial customers and regulatory authorities
- Facts and figures pertaining to the market dynamics, technical advances, regulations, and the impact of region- and industry-specific macroeconomic variables
- A Porter’s Five Forces model, and global supply chain and PESTLE analyses
- Patent activity and key patent grants/publications, along with an analysis of the impact of new developments in sole-use technologies and bioreactors for pharmaceuticals
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
- Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and a venture funding outlook
- Profiles of market leaders, including Danaher Corp, Thermo Fisher Scientific Inc., Sartorius AG and Merck KGaA.
Report Scope
This report summarizes the single-use technologies market, including a market snapshot and company profiles of key players. It provides a comprehensive market breakdown with in-depth information regarding each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges and opportunities for the market. It provides information on emerging technologies and developments in the industry. It analyzes critical market players’ financials, product portfolios and recent activities.
BCC Research analyzed and made projections of each market and its applications, along with forecasts for the next five years. The report also features profiles of leading companies in the biopharmaceutical single-use technologies industry, including Sartorius AG, Danaher Corp, Merck KGaA and Thermo Fisher Scientific Inc.
The market is segmented by geographical region into North America, Europe, Asia-Pacific and the Rest of the World (RoW). Regional analysis is further broken down by country as:
- North America: The U.S., Canada and Mexico.
- Europe: Germany, the U.K., France, Italy, Spain and the Rest of Europe.
- Asia-Pacific: China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific.
Data for market estimates have been provided for 2021 and 2022 as the historical years, 2023 as the base year and forecast through 2029.
Report Synopsis
| Report Metrics | Details | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||
| Base year market size | $5.8 billion | ||||||||||||||
| Market size forecast | $11.2 billion | ||||||||||||||
| Growth rate | CAGR of 11.6% for the forecast period of 2024-2029 | ||||||||||||||
| Units considered | $ Millions | ||||||||||||||
| Segments covered | Technology, Component, Application, End User, and Region | ||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America, Middle East and Africa | ||||||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, France, U.K., Spain, Italy, China, India, Japan, South Korea, and Australia | ||||||||||||||
| Key Market Drivers |
|
||||||||||||||
| Companies studied |
|
||||||||||||||
Frequently Asked Questions (FAQs)
- Sartorius AG
- Danaher Corp.
- Merck KGaA
- Thermo Fischer Scientific Inc.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Biosimilars: Global Markets
The global biosimilars market was valued at $23.8 billion in 2023. The market is expected to grow from $28.5 billion in 2024 to $69.2 billion by 2029, at a compound annual growth rate (CAGR) of 19.4% from 2024 through 2029.
Global Markets for Media, Sera and Reagents in Biotechnology
The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Cell Line and Membrane Market
The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.
Human Microbiome-based Drugs and Diagnostics: Global Markets
The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.
Global Microbiome Sequencing Market
The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.
Proteomics: Technologies and Global Markets
The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Top Trending Reports
Next-Generation Advanced Batteries: Global Markets
The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Report Highlights
The global market for single-use technologies in biopharmaceutical manufacturing should grow from $4.3 billion in 2021 to $7.3 billion by 2026 with a compound annual growth rate (CAGR) of 11.3% for the period of 2021-2026.
Report Includes
- 208 data tables and 22 additional tables
- An overview of the global market for single-use technologies for the biopharmaceutical industry
- Estimation of the market size and analyses of global market trends, with data from 2018-2021, with projections of compound annual growth rates (CAGRs) through 2026
- Discussion on present and future opportunities and key factors influencing the single-use technologies and bioreactors for pharmaceuticals
- Quantification of market applications, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and anticancer drugs
- Highlights of the market potential for single-use technologies for the biopharmaceutical industry, based on technology, component, application, end user, and region
- Description of biologics manufacturing process including upstream and downstream processing and cell harvesting and clarification, and information on single-use technology (SUT)
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast, and assessment of new developments in the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Company profiles of major players, including Merck KGaA, Thermo Fisher Scientific Inc., General Electric Co., Danaher Corp., and Sartorius AG
Report Highlights
The global single-use technology in the biopharmaceutical market should reach $5.9 billion by 2024 from $3.5 billion in 2019 at a compound annual growth rate (CAGR) of 11.3% for the period of 2019 to 2024.
Report Includes
- 58 data tables and 18 additional tables
- An overview of the global market for single-use technologies for the biopharmaceutical industry
- Analyses of global market trends, with data from 2018, estimates for 2019 and projections of CAGRs through 2024
- Discussion on present and future opportunities and key factors influencing the single-use technologies and bioreactors for pharmaceuticals
- Quantification of market applications, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and anticancer drugs
- Impact analysis on pharmaceutical, biotechnology and healthcare sectors
- Coverage of new product developments and technologies, mergers & acquisitions, partnership & collaboration and new product launches in the industry
- Profiles of major players in the industry, including Aber Instruments Ltd., Corning Inc., General Electric Co., Parker Hannifin Corp., Repligen Corp., Sartorius AG, and Thermo Fisher Scientific Inc.
Report Highlights
The global market for single-use technology reached $2.7 billion in 2016. The market should reach over $4.3 billion by 2021, growing at a compound annual growth rate (CAGR) of 10.1% from 2016 to 2021.
Report Includes
- An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters.
- Analyses of global market trends, with data from 2014, 2015 and 2016, and projections of CAGRs through 2021.
- In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges.
- Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs.
- Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares.
- Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns.
- Relevant patent analysis.
Report Highlights
The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.
Report Includes
- An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters.
- Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
- In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges.
- Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs.
- Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares.
- Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns.
- Relevant patent analysis.
Report Highlights
The global market for single-use technologies for biopharmaceuticals was valued at $720 million in 2011 and should reach $985.2 million in 2012. Total market value is expected to reach nearly $2.4 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 19.1%.
Report Includes
- An overview of biopharmaceutical single-use technologies, which aids the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges
- Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs
- Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares
- Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns
- Comprehensive company profiles of existing and potential market players
- Patent analysis.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More